Baxion
Screening
Tags
Alerts
Theme
Neurosense Therapeutics Ltd.
NRSN
·
NASDAQ
·
$0.87
Share Price as of 11/2
·
$22M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
03/31/26
20-F
Annual report (foreign)
04/07/25
20-F
Annual report (foreign)
04/04/24
20-F
Annual report (foreign)
03/22/23
20-F
Annual report (foreign)
04/14/22
Disclosures
Filter
6-K
Foreign issuer report
10/26/26
6-K
Foreign issuer report
10/19/26
6-K
Foreign issuer report
10/13/26
6-K
Foreign issuer report
10/02/26
6-K
Foreign issuer report
09/25/26
Prospectuses and Registrations
Filter
F-3/A
Shelf registration (foreign, amended)
07/30/26
F-3
Shelf registration (foreign)
01/29/26
424B3
Prospectus
11/26/25
F-3
Shelf registration (foreign)
10/28/25
POS AM
Post-effective amendment
08/15/25
Proxies
Filter
No matching filings.
Ownership
Filter
Form 4
Insider transaction
06/17/26
Form 4
Insider transaction
06/17/26
Form 3
Initial insider ownership
04/01/26
Form 4
Insider transaction
04/01/26
Form 3
Initial insider ownership
03/31/26
Other
Filter
EFFECT
Request for effectiveness
07/31/26
EFFECT
Request for effectiveness
11/25/25
CORRESP
Correspondence with the SEC
11/24/25
EFFECT
Request for effectiveness
08/18/25
EFFECT
Request for effectiveness
08/18/25
Latest Filings
Filter
6-K
Foreign issuer report
10/26/26
6-K
Foreign issuer report
10/19/26
6-K
Foreign issuer report
10/13/26
6-K
Foreign issuer report
10/02/26
6-K
Foreign issuer report
09/25/26
Ownership
Filter
Form 4
Insider transaction
06/17/26
Form 4
Insider transaction
06/17/26
Form 3
Initial insider ownership
04/01/26
Form 4
Insider transaction
04/01/26
Form 3
Initial insider ownership
03/31/26